Different characteristics of triptans

Journal of Headache and Pain

Volumn 5, Issue SUPPL. 2, 2004, Pages

  Pini, Luigi A ^a   Brovia, Daria ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Anti migraine drugs; Efficacy; Pharmacokinetics; Safety; Triptans

Indexed keywords

ALCOHOL; ALMOTRIPTAN; ANTIMIGRAINE AGENT; DRUG METABOLITE; ELETRIPTAN; ERGOT DERIVATIVE; FROVATRIPTAN; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NARATRIPTAN; PAROXETINE; PLACEBO; PROPRANOLOL; RIZATRIPTAN; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; VERAPAMIL; ZOLMITRIPTAN;

AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CENTRAL NERVOUS SYSTEM DISEASE; COMORBIDITY; DIZZINESS; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG CONCENTRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; HUMAN; MEDICAL DECISION MAKING; MIGRAINE; NAUSEA AND VOMITING; PARESTHESIA; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SOMNOLENCE; THORAX DISEASE; VERTIGO; XEROSTOMIA;

EID: 11344290829     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10194-004-0122-5     Document Type: Article

References (12)

1. Hargraves RJ, Shepherd SL (1999) Pathophysiology of migraine - new insights. Can J Neurol Sci 26[Suppl 3]:S12-S19
2. Tfelt-Hansen P, Saxena PR, Daholf C et al (2000) Ergotamine in the acute treatment of migraine: A review and European consensus. Brain 123:9-18
3. Cady RK, Wendt JK, Kirchner JR, Sargent JD et al (1991) Treatment of acute migraine with subcutaneous Sumatriptan. JAMA 265:2831-2835
4. The Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with Sumatriptan. N Engl J Med 325:316-321
5. Daholf C (1999) Sumatriptan nasal spray in the acute treatment of migraine: A review of clinical studies. Cephalalgia 19:769-778
6. Pfaffenrath V, Cunin G, Sjionell G, Prendergast S (1998) Efficacy and safety of Sumatriptan tablets (25 mg, 50 mg and 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral Sumatriptan. Headache 38:184-190
7. Sargent J, Kirchner JR, Davis R, Kirkhart B (1995) Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: evaluation of three dosage strengths. Neurology 45[Suppl 7]:S10-S14
8. Robert M, Cabarrocas X, Fernandez FJ, Zayas JM, Ferrer P, for and on behalf of the Almotriptan Multiple Attacks Study Group (1998) Efficacy and tolerability of oral Almotriptan in the treatment of migraine. Cephalalgia 18:406
9. Dahlof CG, Dodick DW, Dowson AJ, Pascual J (2002) How does Almotriptan compare to other triptans? A review of data from placebo-controlled clinical trials. Headache 42:99-113
10. Visser WH, Jaspers NM, de Vriend RH, Ferrari MD (1996) Risk factors for headache recurrence after Sumatriptan: A study of 366 migraine patients. Cephalalgia 16:264-269
11. Ferrari MD (1999) How to assess and compare drugs in the management of migraine: Success rates in terms of response and recurrence. Cephalalgia 19[Suppl 23]:2-8
12. Maassen Van Den Brink A, Reekers M, Baxx WA, Ferrari MD, Saxena PR (1998) Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 98:25-30